Ilse Schuitema and Leo M.J. de Sonneville, Leiden University, Leiden; Ilse Schuitema, Marita Daams, Frederik Barkhof, Eline van Dulmen-den Broeder, and Anjo J.P. Veerman, Vrije Universiteit University Medical Center; Helena J. van der Pal and Cor van den Bos, Academic Medical Center, Amsterdam, the Netherlands; Sabine Deprez, Anne Uyttebroeck, and Stefan Sunaert, University Hospitals Leuven; Wim Van Hecke, icoMetrix, Leuven, Belgium.
J Clin Oncol. 2013 Sep 20;31(27):3378-88. doi: 10.1200/JCO.2012.46.7050. Epub 2013 Aug 19.
CNS-directed chemotherapy (CT) and cranial radiotherapy (CRT) for childhood acute lymphoblastic leukemia or lymphoma have various neurotoxic properties. This study aimed to assess their impact on the maturing brain 20 to 30 years after diagnosis, providing a much stronger perspective on long-term quality of life than previous studies.
Ninety-three patients treated between 1978 and 1990 at various intensities, with and without CRT, and 49 healthy controls were assessed with magnetic resonance diffusion tensor imaging (DTI) and neuropsychological tests. Differences in fractional anisotropy (FA)-a DTI measure describing white matter (WM) microstructure-were analyzed by using whole brain voxel-based analysis.
CRT-treated survivors demonstrated significantly decreased FA compared with controls in frontal, parietal, and temporal WM tracts. Trends for lower FA were seen in the CT-treated survivors. Decreases in FA correlated well with neuropsychological dysfunction. In contrast to the CT group and controls, the CRT group showed a steep decline of FA with age at assessment. Younger age at cranial irradiation and higher dosage were associated with worse outcome of WM integrity.
CRT-treated survivors show decreased WM integrity reflected by significantly decreased FA and associated neuropsychological dysfunction 25 years after treatment, although effects of CT alone seem mild. Accelerated aging of the brain and increased risk of early onset dementia are suspected after CRT, but not after CT.
儿童急性淋巴细胞白血病或淋巴瘤的中枢神经系统定向化疗(CT)和颅放射治疗(CRT)具有各种神经毒性。本研究旨在评估它们在诊断后 20 至 30 年内对成熟大脑的影响,为长期生活质量提供比以往研究更强有力的视角。
93 名患者于 1978 年至 1990 年期间接受不同强度的治疗,包括 CRT 和无 CRT,并与 49 名健康对照者一起接受磁共振扩散张量成像(DTI)和神经心理学测试。使用全脑体素基于分析方法分析描述白质(WM)微观结构的各向异性分数(FA)-DTI 测量值的差异。
与对照组相比,CRT 治疗的幸存者在前额、顶叶和颞叶 WM 束中 FA 明显降低。CT 治疗幸存者也出现 FA 降低的趋势。FA 的降低与神经心理功能障碍密切相关。与 CT 组和对照组相比,CRT 组在评估时的 FA 随年龄的增长呈急剧下降趋势。颅照射年龄较小和剂量较高与 WM 完整性的预后较差相关。
尽管 CT 单独治疗的影响似乎较轻,但 CRT 治疗的幸存者在治疗后 25 年仍表现出 WM 完整性降低,表现为 FA 明显降低和相关的神经心理功能障碍。怀疑 CRT 后会加速大脑老化和增加早发性痴呆的风险,但 CT 后不会。